USPTO USPTO 2004 ABANDONED - NO STATEMENT OF USE FILED

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke wurde als Bildmarke am 21.05.2004 beim Amerikanischen Patent- und Markenamt angemeldet. Der aktuelle Status der Marke ist "ABANDONED - NO STATEMENT OF USE FILED".

Markendetails

Markenform Bildmarke
Aktenzeichen 78423268
Anmeldedatum 21. Mai 2004
Veröffentlichungsdatum 01. November 2005

Markeninhaber

4840 Pearl East Circle
80301 Boulder
US

Markenvertreter

Waren und Dienstleistungen

1 Chemicals for use in science and in pharmaceutical manufacture; chemical preparations, namely carriers and excipients in the nature of chemical additives for use in the manufacture of pharmaceuticals
5 Pharmaceutical substances and preparations, namely, anticancer agents; genetic substances for use in treatment of neurodegenerative diseases; chemical preparations, namely carriers and excipients in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; diagnostic reagents and pharmaceutically active agents for medical research use for treatment of cancer and neurodegenerative disorders
40 Custom manufacturing services for the preparation of pharmaceuticals and pharmaceutically active materials; processing of pharmaceuticals and pharmaceutically active materials; extraction of chemical substances from plant materials and purification of the crude plant extract; treatment of plant materials for use in research and development and in pharmaceutical manufacture
42 Scientific research comprising medical and genetic analysis and investigation of clinical trial recruits for the benefit of pharmaceutical companies; licensing of patents and intellectual property; chemical analysis; scientific and medical research; research services relating to the development and testing of pharmaceuticals; scientific research relating to genetics and oncology; development and licensing of anticancer agents; developing cures for cancer and hereditary disease and diseases involving cellular dysfunction other than cancer and hereditary diseases.
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1378423268